Study of ELA026 for Treatment of Secondary Hemophagocytic Lymphohistiocytosis in Patients with Lymphoma Who Have Not Received Previous Treatment
- Substances:–
Italy- Participants:0–17 years · 18–64 years · 65+ years
- Sponsor:Electra Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to Italy152 clinical trials in Trieste, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
Italy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on blood disorders and malignancies, including innovative treatments for leukemia and lymphoma. Clinical trials are evaluating new therapeutic combinations and targeted approaches.
Studies are exploring both chemotherapy-free alternatives and novel drug combinations to improve patient outcomes.
Advanced research into respiratory conditions, with a particular focus on progressive lung disorders. Studies are evaluating new therapeutic approaches for managing chronic conditions.
Trials aim to assess treatment efficacy through measurement of vital capacity and disease progression markers.
Comprehensive studies of various cancer types, incorporating innovative therapeutic approaches and targeted treatments. Focus on both rare and common malignancies.
Research emphasizes personalized medicine approaches and combination therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.